[go: up one dir, main page]

KR890011609A - Live vaccine against spores by using a parasitoid - Google Patents

Live vaccine against spores by using a parasitoid Download PDF

Info

Publication number
KR890011609A
KR890011609A KR1019890000179A KR890000179A KR890011609A KR 890011609 A KR890011609 A KR 890011609A KR 1019890000179 A KR1019890000179 A KR 1019890000179A KR 890000179 A KR890000179 A KR 890000179A KR 890011609 A KR890011609 A KR 890011609A
Authority
KR
South Korea
Prior art keywords
cleavage
composition
water soluble
decapsulated
suspension
Prior art date
Application number
KR1019890000179A
Other languages
Korean (ko)
Inventor
싱 보갈 벨버
Original Assignee
죤 찰머스 고던
에이.에이취.로빈스 캄파니, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죤 찰머스 고던, 에이.에이취.로빈스 캄파니, 인코포레이티드 filed Critical 죤 찰머스 고던
Publication of KR890011609A publication Critical patent/KR890011609A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/947—Microorganisms using protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음No content

Description

구충 분열제를 사용한 포자충증에 대한 생백신Live vaccines against spores with antiparasitic drugs

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (15)

탈낭된 생구충 분열체의 생존력을 상당히 연장시키기에 충분한 양으로, 하이드로졸, 겔, 젤라틴, 셀룰로수, 셀룰로스 유도체, 및 알긴산염을 포함한 다당류 고무중에서 선택된 적어도 하나의 수용성 중합체성 점도 증진제를 함유하고, 등장성 및 pH가 생리학적으로 평형을 이루는, 수성배지중의 상기 분열체의 현탁액으로 구성됨을 특징으로 하는, 포자층증질환에 대한 온혈동물의 백신 접종용 조성물.Contains at least one water-soluble polymeric viscosity enhancer selected from polysaccharide rubbers including hydrosols, gels, gelatin, cellulose waters, cellulose derivatives, and alginates in an amount sufficient to significantly prolong the viability of the decapsulated protozoan cleavage And isotonicity and pH are physiologically balanced, consisting of a suspension of the dividing body in an aqueous medium, the composition for vaccination of warm-blooded animals against spore layer of disease. 제1항에 있어서, 수용성 다당류 고무가 알긴산 나트륨인 조성물.The composition of claim 1 wherein the water soluble polysaccharide rubber is sodium alginate. 제1항에 있어서, 분열체가 에이메리아 테넬라(Eimeria tenella)종의 분열체인 방법.The method of claim 1, wherein the cleavage is a cleavage of the species Eimeria tenella. 탈낭된 생구층 분열체의 생존력을 상당히 연장시키기에 충분한 양으로, 하이드로졸, 겔, 젤라틴, 셀룰로스. 셀룰로스 유도체 및 알긴산염을 포함한 다당류 고무중에서 선택된 적어도 하나의 수용성 중합체성 점도 증진제를 함유하고, 등장성 및 pH가 생리학적으로 평형을 이루는, 상기 분열체의 현탁액을 경화된 중합체성 물질로 구성된 마이크로캅셀 벽 내부에 함유하는 마이크로캅셀로 이루어짐을 특징으로 하는, 포자층증 질환에 대한 온혈동물의 백신 접종용 조성물.Hydrosol, gel, gelatin, cellulose in an amount sufficient to significantly prolong the viability of the decapsulated germline fission. A microcapsule consisting of a cured polymeric material containing a suspension of said fissile containing at least one water soluble polymeric viscosity enhancer selected from polysaccharide rubbers, including cellulose derivatives and alginates and having a physiologically equilibrium of isotonicity and pH A composition for vaccination of warm-blooded animals against spores of the disease, characterized in that consisting of microcapsules contained within the wall. 제4항에 있어서, 수용성 다당류 고무가 알긴산 나트륨, 마이크로캅셀 벽이 알긴산 칼슘은 조성물.The composition of claim 4 wherein the water soluble polysaccharide rubber is sodium alginate and the microcapsule wall is calcium alginate. 제4항에 있어서, 분열체가 에이메리아 테넬라 종의 분열체인 조성물.5. The composition of claim 4, wherein the cleavage is a cleavage of the Emeria tenella species. 용액중에 알긴산 나트륨을 함유하며 등장성 및 pH가 생리학적으로 평형을 이루는 탈낭된 구출분열체의 현탁액으로 이루어지고, 25℃에서 100내지 400CP범위의 점도를 갖는 조성물.A composition comprising sodium alginate in solution, consisting of a suspension of decapsulated rescue fissures that isotonic and pH is physiologically balanced, and has a viscosity in the range of 100 to 400 CP at 25 ° C. 제7항에 있어서, 분열체의 종이 에이메리아 테넬라인 조성물.8. The Ameria tenellane composition of claim 7, wherein the cleavage species is a species. 탈낭된 생구충 분열체의 생존력을 상당히 연장시키기에 충분한 양으로, 하이드로졸, 겔, 젤라틴 및 알긴상염을 포함한 다당류 고무중에서 선택된 적어도 하나의 수용성 중합체성 점도 증진제를 함유하고, 등장성 및 pH가 생리학적으로 평형을 이루는 상기 분열체의 현탁액으로 구성된 조성물을 온혈동물의 백신 접종 방법.Contains at least one water-soluble polymeric viscosity enhancer selected from polysaccharide rubbers, including hydrosols, gels, gelatin and alginate salts, in an amount sufficient to significantly prolong the viability of the decapsulated protozoan cleavage, and isotonic and pH A method of vaccination of a warm blooded animal with a composition consisting of a suspension of said cleavage, which is academically balanced. 제9항에 있어서, 수용성 다당류 고무가 알긴산 나트륨인 방법.The method of claim 9 wherein the water soluble polysaccharide rubber is sodium alginate. 제9항에 있어서, 동물이 닭인 방법.The method of claim 9, wherein the animal is a chicken. 제9항에 있어서, 동물이 닭이고, 조성물을 목의 뒷덜미에 피하 투여하는 방법.The method of claim 9, wherein the animal is a chicken and the composition is administered subcutaneously to the back of the neck. 탈낭된 생구층 분열체의 생존력을 상당히 연장시키기에 충분한 양으로, 하이드로졸, 겔, 젤라틴, 셀룰로스, 셀룰로스 유도체 및 알긴산염을 포함한 다당류 고무중에서 선택된 적어도 하나의 수용성 중합체성 점도 증진제를 함유하고, 등장성 및 pH가 생리학적으로 평형을 이루는 상기 분열체의 현탁액을 경화된 중합체성 물질로 구성하는 마이크로캅셀 벽 내부에 함유하는 마이크로캅셀로 이루어진 조성물을 온혈동물에 투여함을 특징으로 하는, 포자층층질환에 대한 온혈동물의 백신 접종 방법.Contains at least one water soluble polymeric viscosity enhancer selected from polysaccharide rubbers including hydrosol, gel, gelatin, cellulose, cellulose derivatives and alginates, in an amount sufficient to significantly prolong the viability of the decapsulated glomerular cleavage Spore layer disease, characterized by administering to the warm-blooded animal a composition consisting of microcapsules containing a suspension of said cleavage in which the sex and pH are physiologically balanced inside the microcapsule wall composed of a cured polymeric material. Vaccination method for warm blooded animals. 제13항에 있어서, 사용된 수용성 다당류 고무가 알긴산 나트륨이고 마이크로캅셀벽이 알긴산 칼슘인 방법.The method of claim 13 wherein the water soluble polysaccharide rubber used is sodium alginate and the microcapsule wall is calcium alginate. 제13항에 있어서, 분열체가 에이메리마 테넬라 종의 분열체인 방법.The method of claim 13, wherein the cleavage is a cleavage of the Amymeric tenella species. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019890000179A 1988-01-11 1989-01-11 Live vaccine against spores by using a parasitoid KR890011609A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/141,953 1988-01-11
US07/141,953 US4808404A (en) 1988-01-11 1988-01-11 Live vaccine for coccidiosis utilizing coccidial sporozoites

Publications (1)

Publication Number Publication Date
KR890011609A true KR890011609A (en) 1989-08-21

Family

ID=22497950

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000179A KR890011609A (en) 1988-01-11 1989-01-11 Live vaccine against spores by using a parasitoid

Country Status (13)

Country Link
US (1) US4808404A (en)
EP (1) EP0325359A1 (en)
JP (1) JPH01190634A (en)
KR (1) KR890011609A (en)
AU (1) AU618058B2 (en)
DK (1) DK9089A (en)
FI (1) FI890118L (en)
IL (1) IL88036A0 (en)
NO (1) NO890103L (en)
NZ (1) NZ227570A (en)
PH (1) PH24966A (en)
PT (1) PT89419A (en)
ZA (1) ZA89231B (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273901A (en) * 1984-07-05 1993-12-28 Enzon Corp. Genetically engineered coccidiosis sporozoite 21.5 Kb antigen, ac-6b
US5279960A (en) * 1984-07-05 1994-01-18 Enzon Corp. 25 KD coccidial antigen of eimeria tenella
DE3785404T2 (en) * 1986-08-18 1993-07-29 British Tech Group Vaccines.
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5068104A (en) * 1988-08-01 1991-11-26 A. H. Robins Company Incorporated Live vaccine for coccidiosis utilizing coccidial sporozoites
US5015476A (en) * 1989-08-11 1991-05-14 Paravax, Inc. Immunization implant and method
US6008342A (en) * 1991-07-12 1999-12-28 Roche Vitamins Inc. DNA encoding eimeria antigen
US5403581A (en) * 1991-07-12 1995-04-04 Hoffmann-La Roche Inc. Coccidiosis vaccines
AU4932493A (en) * 1992-09-25 1994-04-26 Dynagen, Inc. An immunobooster for delayed release of immunogen
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine
US5549899A (en) * 1992-12-04 1996-08-27 University Technologies International, Inc. Giardia vaccine
ES2158108T3 (en) 1995-06-07 2001-09-01 Pfizer IN OVO VACCINATION AGAINST COCCIDIOSIS.
SK282004B6 (en) 1995-06-07 2001-10-08 Pfizer Inc. Use of living sporozoids or merozoids eimeria for production of vaccine to inoculate domestication birds in ovo against coccidiosis
US6274369B1 (en) 1996-02-02 2001-08-14 Invitrogen Corporation Method capable of increasing competency of bacterial cell transformation
US5891692A (en) 1996-03-29 1999-04-06 Life Technologies, Inc. Method for increasing the viability and transformation ability of bacteria during or after storage at low temperatures
WO1998035018A1 (en) 1997-02-12 1998-08-13 Life Technologies, Inc. Methods for lyophilizing competent cells
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
DE19828322A1 (en) * 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh New coccidiocide vaccine comprises inactivated, immunogenic sporocytes of pathogenic Eimeria species
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US6344340B1 (en) 1999-03-01 2002-02-05 Novus International, Inc. Viability assay for sporocyst-forming protozoa
US20040247607A1 (en) * 1999-11-08 2004-12-09 Novus International, Inc. Use of surfactants to stabilize oocysts
PT1280521E (en) 2000-05-12 2005-10-31 Pharmacia & Upjohn Co Llc VACCINE COMPOSITION, METHOD FOR PREPARATION, AND METHOD OF VACCINATION OF VERTEBRATES
DE10040174A1 (en) * 2000-08-17 2002-02-28 Bayer Ag Use of triazinetrione sulfones to combat coccidioses
US20020160022A1 (en) * 2000-11-08 2002-10-31 Schasteen Charles S. Methods and compositions for the control of coccidiosis
KR20040021678A (en) * 2001-08-30 2004-03-10 엠브렉스, 인코포레이티드 Improved methods for producing oocysts
AU2002331847A1 (en) * 2001-09-14 2003-04-01 Invitrogen Corporation Composition for stabilizing biological materials
TWI348376B (en) * 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
CN100528225C (en) * 2002-05-21 2009-08-19 先灵-普劳有限公司 Methods for the in vitro culture of sporozoea species and uses thereof
WO2004035028A1 (en) * 2002-10-17 2004-04-29 Gosudarstvenny Nauchny Tsentr Virusologii I Biotekhnologii 'vektor' Method for producing the microcapsulated form of a live viral vaccine
US7354593B2 (en) 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
EP1742656B1 (en) 2004-03-12 2010-06-16 University Of Georgia Research Foundation, Inc. Novel peanut skin extract as a vaccine adjuvant
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
US20080194006A1 (en) * 2007-02-08 2008-08-14 Embrex, Inc. Methods of releasing sporocysts from oocysts using controlled shear forces
US20180153945A1 (en) * 2016-12-05 2018-06-07 The United States Of America, As Represented By The Secretary Of Agriculture Oral e. coli vector-based vaccine for prevention of coccidiosis in poultry
US20180208885A1 (en) 2017-01-24 2018-07-26 Mary Ann Pfannenstiel Antibiotic-free compositions for the prevention or control of coccidiosis
CN108619498A (en) 2018-05-18 2018-10-09 佛山市正典生物技术有限公司 A kind of coccidiosis of rabbit vaccine and its application

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2849226A1 (en) * 1977-11-14 1979-05-17 Unilever Nv METHOD OF PROMOTING POULTRY GROWTH, MEANS OF IMPLEMENTING IT AND PRODUCING IT
GB8326633D0 (en) * 1983-08-04 1983-11-09 Unilever Plc Compositions
US4639372A (en) * 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens

Also Published As

Publication number Publication date
US4808404A (en) 1989-02-28
PT89419A (en) 1990-02-08
DK9089A (en) 1989-07-12
FI890118L (en) 1989-07-12
NZ227570A (en) 1990-07-26
IL88036A0 (en) 1989-06-30
JPH01190634A (en) 1989-07-31
AU2838489A (en) 1989-07-13
EP0325359A1 (en) 1989-07-26
PH24966A (en) 1990-12-26
NO890103L (en) 1989-07-12
DK9089D0 (en) 1989-01-10
AU618058B2 (en) 1991-12-12
NO890103D0 (en) 1989-01-10
ZA89231B (en) 1989-10-25
FI890118A0 (en) 1989-01-10

Similar Documents

Publication Publication Date Title
KR890011609A (en) Live vaccine against spores by using a parasitoid
KR870000924A (en) Method for preparing controlled release inserter for growth hormone
ES2053567T3 (en) A PROCEDURE FOR THE PREPARATION OF A CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION.
DK30187D0 (en) PHARMACEUTICAL PREPARATION FOR GETTING A HIGH-VIKOS HYDROGEL OR SUSPENSION
FI863990A0 (en) Ophthalmological carrier composition for a pharmaceutical or diagnostic substance
NO924104D0 (en) Powder formulation with flow controlled release
BE901359A (en) PHARMACEUTICAL COMPOSITION WITH CONTROLLED ABSORPTION.
ES2153034T3 (en) SUPPLY SYSTEM IN MICROPARTICLES.
KR890004686A (en) Sustained release Etodolac
KR880701551A (en) Pharmaceutical prescription
FR2613224B1 (en) EXTENDED RELEASE BILAYER DOSAGE FORM
ES2095964T3 (en) A COMPOSITION OF LIQUID EXCIPIENT THAT FORMS A GEL.
ATE138940T1 (en) WATER SOLUBLE HYALURONIC ACID DERIVATIVES
KR890009376A (en) Spray dried ibuprofen
ES2034365T3 (en) A CHEWING GUM WITH LASTING SOFTNESS.
RO91501A (en) PROCESS FOR OBTAINING A DRUG COMPOSITION WITH LIVING DEMICROORGANISM CONTENT
KR880701543A (en) Microgranular formulations useful for releasing biologically active substances in the long term of animals
ATE116859T1 (en) BLOOD PRESSURE-LOWERING PREPARATION.
BE901328A (en) PHARMACEUTICAL COMPOSITION WITH CONTROLLED ABSORPTION.
KR900015768A (en) Solid gel external drug delivery system
KR920007571A (en) Nutritional composition and preparation method thereof
Dunn et al. Vaccines in aquaculture: the search for an efficient delivery system
KR900002774A (en) Injection
GB1316168A (en) Poultry vaccine
KR880008808A (en) Parenteral suspensions

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19890110

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid